Frontier Capital Management CO LLC Adaptive Biotechnologies Corp Transaction History

Frontier Capital Management CO LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $5,646 - $8,424	902 Added 0.49%	184,433 $1.41 Million
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $332,241 - $647,614	-51,114 Reduced 21.78%	183,531 $1.31 Million
Q2 2022 Jul 20, 2022	SELL	$6.4 - $14.73 $2.32 Million - $5.34 Million	-362,228 Reduced 60.69%	234,645 $1.9 Million
Q1 2022 Apr 14, 2022	BUY	$10.12 - $28.9 $4.09 Million - $11.7 Million	404,561 Added 210.37%	596,873 $8.29 Million
Q4 2021 Jan 19, 2022	BUY	$25.17 - $36.85 $3.19 Million - $4.67 Million	126,722 Added 193.2%	192,312 $5.4 Million
Q3 2021 Oct 19, 2021	SELL	$30.02 - $39.87 $1.12 Million - $1.49 Million	-37,296 Reduced 36.25%	65,590 $2.23 Million
Q2 2021 Aug 09, 2021	SELL	$32.22 - $44.59 $4.31 Million - $5.96 Million	-133,701 Reduced 56.51%	102,886 $4.2 Million
Q1 2021 May 13, 2021	SELL	$37.26 - $67.74 $17.2 Million - $31.2 Million	-460,371 Reduced 66.05%	236,587 $9.53 Million
Q4 2020 Jan 19, 2021	SELL	$45.01 - $65.47 $5.39 Million - $7.84 Million	-119,709 Reduced 14.66%	696,958 $41.2 Million
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $2.19 Million - $2.99 Million	61,205 Added 8.1%	816,667 $39.7 Million
Q2 2020 Jul 17, 2020	SELL	$24.95 - $48.38 $4.77 Million - $9.25 Million	-191,248 Reduced 20.2%	755,462 $36.5 Million
Q1 2020 Apr 16, 2020	BUY	$16.96 - $34.16 $10.5 Million - $21.1 Million	618,353 Added 188.32%	946,710 $26.3 Million
Q4 2019 Feb 14, 2020	BUY	$24.56 - $32.8 $8.06 Million - $10.8 Million	328,357 New	328,357 $9.82 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.